High materiality7/10
Insulet downgraded to Market Perform from Outperform at Leerink
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Leerink Partners lowers rating to Market Perform; target $145. Current price $133.26.
- Target set at $145 by Leerink Partners; rating downgraded.
Key facts
- 01
Target: $145
- 02
Posted price: $133.26
- 03
Analyst firm: Leerink Partners
- 04
Analyst: Mike Kratky
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.